TETmedical
Industrial Biotechnology · Diagnostic Tests & IVD
$6Mtotal raised · 4 rounds on record
$3.5Mlatest round · Venture round · Jun 2026 · 5 mo ago
1backers · Launchpad Venture Group
$506kgrants · 2 grants · CORDIS
Overview
About TETmedical, Inc, is a Delaware C-corp founded in November 2021 by Professors Alex Travis and Roy Cohen of Cornell University and Dr. David R.
Key facts
These are the key facts about TETmedical on Alion as of Nov 13, 2026. It was founded in 2021. It has raised $6M in 2 funding rounds. The latest round is Venture - Series Unknown of $3.5M, announced in 2026.
- Founded
- 2021Alion company profile, updated Sep 28, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $6MSum of 2 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $3.5M · Jun 12, 2026SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$6M
4 rounds on record
Latest round
$3.5M
Venture round · Jun 2026 · 5 mo ago
Team
11-50
employees, estimated range
Grants
$506k
2 grants · CORDIS
Backers
1
Launchpad Venture Group
The money's age
Fresh money
5 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 12
Raised a round Venture round $3.5M · SEC Form D
Aug 14, 2025
Won a grant $181k · CORDIS
Dec 15, 2023
Won a grant $325k · CORDIS
May 31, 2023
Raised a round Venture round $2.5M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $3.5M | — | SEC Form D |
| Grant | Aug 2025 | $181k | — | CORDIS |
| Grant | Dec 2023 | $325k | — | CORDIS |
| Venture round | May 2023 | $2.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | TETmedical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
David FischellExecutive Officer, DirectorSEC Form D
Alex TravisExecutive Officer, DirectorSEC Form D
Roy CohenExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Our storyRejuvetech Ltd was founded in 2013 by David Hogg, who, having obtained a Ph.D in organic chiral chemistry from Bangor University…
Our Story Centerline Biomedical was born out of a collaboration between science and medicine. Vikash Goel, our Founder and CTO, studied…
Nexus helps businesses make the right connections, providing access to research, talent and facilities at the University of Leeds.
The idea for Crowdmark arose as a solution to a real-life challenge. When University of Toronto Mathematics Professor James Colliander was…
Cleaner, safer, more efficient chemical manufacture. A spinout from the University of Oxford, commercialising a novel biotechnology.
Imago Rehab’s mission is to make high-quality rehabilitation available to anyone recovering from a neurological or cardiovascular condition.
People
David Fischell
Executive Officer, Director
Alex Travis
Executive Officer, Director
Roy Cohen
Executive Officer
Christine Bunt
Director
John Conley
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Launchpad Venture GroupVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer, Veteran Life Sciences Entrepreneurs and Company Builders
New Directors Bring Track Record of Founding, Scaling, and Exiting Institutionally-Backed MedTech and Life Sciences Companies as TETmedical Advances Its Pivotal StudyFAIR HAVEN, N.J and ITHACA, N.Y., Sept. 22, 2026 (GLOBE NEWSWIRE) -- TETmedical, Inc., a
Read more
Report
TETmedical Strengthens Board of Directors with Appointment of Marc Lebel and Patrick McBrayer, ...
Read more
Report
Tetmedical Strengthens Board Of Directors With Appointment Of Marc Lebel And Patrick Mcbrayer, Veteran Life Sciences Entrepreneurs And Company Builders
Read more
Report
TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke
FAIR HAVEN, N.J. and ITHACA, N.Y., June 22, 2026 (GLOBE NEWSWIRE) -- TETmedical, Inc., a clinical stage medical diagnostics company developing rapid tools for diagnosing acute neurological injury based on its patented Tethered Enzyme Technology (TET), tod
Read more
Report
How to cite this page
Alion, "TETmedical: key facts", as of Nov 13, 2026. https://alion.io/company/tetmedical
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0